Literature DB >> 24379286

Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition.

Ashley L DuMont1, Pauline Yoong, Xiang Liu, Christopher J Day, Nicole M Chumbler, David B A James, Francis Alonzo, Nadine J Bode, D Borden Lacy, Michael P Jennings, Victor J Torres.   

Abstract

The bicomponent leukotoxins produced by Staphylococcus aureus kill host immune cells through osmotic lysis by forming β-barrel pores in the host plasma membrane. The current model for bicomponent pore formation proposes that octameric pores, comprised of two separate secreted polypeptides (S and F subunits), are assembled from water-soluble monomers in the extracellular milieu and multimerize on target cell membranes. However, it has yet to be determined if all staphylococcal bicomponent leukotoxin family members exhibit these properties. In this study, we report that leukocidin A/B (LukAB), the most divergent member of the leukotoxin family, exists as a heterodimer in solution rather than two separate monomeric subunits. Notably, this property was found to be associated with enhanced toxin activity. LukAB also differs from the other bicomponent leukotoxins in that the S subunit (LukA) contains 33- and 10-amino-acid extensions at the N and C termini, respectively. Truncation mutagenesis revealed that deletion of the N terminus resulted in a modest increase in LukAB cytotoxicity, whereas the deletion of the C terminus rendered the toxin inactive. Within the C terminus of LukA, we identified a glutamic acid at position 323 that is critical for LukAB cytotoxicity. Furthermore, we discovered that this residue is conserved and required for the interaction between LukAB and its cellular target CD11b. Altogether, these findings provide an in-depth analysis of how LukAB targets neutrophils and identify novel targets suitable for the rational design of anti-LukAB inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24379286      PMCID: PMC3958006          DOI: 10.1128/IAI.01444-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins.

Authors:  J D Pédelacq; L Maveyraud; G Prévost; L Baba-Moussa; A González; E Courcelle; W Shepard; H Monteil; J P Samama; L Mourey
Journal:  Structure       Date:  1999-03-15       Impact factor: 5.006

2.  Tyrosine72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the staphylococcal gamma-hemolysin to human erythrocytes.

Authors:  K Yokota; Y Kamio
Journal:  Biosci Biotechnol Biochem       Date:  2000-12       Impact factor: 2.043

3.  Purification of the two components of leucocidin from Staphylococcus aureus.

Authors:  A M WOODIN
Journal:  Biochem J       Date:  1960-04       Impact factor: 3.857

4.  Crystal structure of leucotoxin S component: new insight into the Staphylococcal beta-barrel pore-forming toxins.

Authors:  Valérie Guillet; Pierre Roblin; Sandra Werner; Manuela Coraiola; Gianfranco Menestrina; Henri Monteil; Gilles Prévost; Lionel Mourey
Journal:  J Biol Chem       Date:  2004-07-18       Impact factor: 5.157

5.  Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel.

Authors:  R Olson; H Nariya; K Yokota; Y Kamio; E Gouaux
Journal:  Nat Struct Biol       Date:  1999-02

6.  The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis.

Authors:  Lakmal Jayasinghe; Hagan Bayley
Journal:  Protein Sci       Date:  2005-10       Impact factor: 6.725

7.  Staphylococcal coagulase; mode of action and antigenicity.

Authors:  E S DUTHIE; L L LORENZ
Journal:  J Gen Microbiol       Date:  1952-02

8.  Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.

Authors:  D A Colin; I Mazurier; S Sire; V Finck-Barbançon
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 9.  Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.

Authors:  Ashley L DuMont; Victor J Torres
Journal:  Trends Microbiol       Date:  2013-11-11       Impact factor: 17.079

10.  Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model.

Authors:  B E Menzies; D S Kernodle
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  37 in total

1.  Using Quantitative Spectrometry to Understand the Influence of Genetics and Nutritional Perturbations On the Virulence Potential of Staphylococcus aureus.

Authors:  Jessica R Chapman; Divya Balasubramanian; Kayan Tam; Manor Askenazi; Richard Copin; Bo Shopsin; Victor J Torres; Beatrix M Ueberheide
Journal:  Mol Cell Proteomics       Date:  2017-02-14       Impact factor: 5.911

2.  Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.

Authors:  Adriana Badarau; Harald Rouha; Stefan Malafa; Derek T Logan; Maria Håkansson; Lukas Stulik; Ivana Dolezilkova; Astrid Teubenbacher; Karin Gross; Barbara Maierhofer; Susanne Weber; Michaela Jägerhofer; David Hoffman; Eszter Nagy
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

Review 3.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

4.  Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Authors:  Isaac P Thomsen; Gopal Sapparapu; David B A James; James E Cassat; Meera Nagarsheth; Nurgun Kose; Nicole Putnam; Kristina M Boguslawski; Lauren S Jones; James B Wood; Clarence B Creech; Victor J Torres; James E Crowe
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

Review 5.  Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Authors:  András N Spaan; Jos A G van Strijp; Victor J Torres
Journal:  Nat Rev Microbiol       Date:  2017-04-19       Impact factor: 60.633

Review 6.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

7.  Unbiased Identification of Immunogenic Staphylococcus aureus Leukotoxin B-Cell Epitopes.

Authors:  David N Hernandez; Kayan Tam; Bo Shopsin; Emily E Radke; Pegah Kolahi; Richard Copin; François-Xavier Stubbe; Timothy Cardozo; Victor J Torres; Gregg J Silverman
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

8.  Structure-based discovery of a small-molecule inhibitor of methicillin-resistant Staphylococcus aureus virulence.

Authors:  Jie Liu; Lina Kozhaya; Victor J Torres; Derya Unutmaz; Min Lu
Journal:  J Biol Chem       Date:  2020-03-16       Impact factor: 5.157

Review 9.  Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.

Authors:  William E Sause; Peter T Buckley; William R Strohl; A Simon Lynch; Victor J Torres
Journal:  Trends Pharmacol Sci       Date:  2015-12-22       Impact factor: 14.819

10.  Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.

Authors:  Danielle Ahn; Alice Prince
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.